Senior insider sale
Chief Legal Officer at 4D MOLECULAR THERAPEUTICS, INC. — senior position signals high conviction
$109.7K
10.76K shares
What this filing means
BIZILY SCOTT plans to sell 10.76K shares of 4D MOLECULAR THERAPEUTICS, INC. valued at approximately $109.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/17/2025ACC: 0001950047-25-008964
Officer· Chief Legal Officer
Since Mar 2022
10.76K
Shares to sell
$109.7K
Approx. market value
1.64K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
11/17/2025
1.64KTotal acquired1.64K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/17/2025 | Exercise of Stock Options Cash | 1.64K | — |
| Total | 1.64K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
2.68K
Market value
$32.1K
10/24/2025
—Completed
Units to sell
1.64K
Market value
$16.6K
10/16/2025
—Completed
Units to sell
2.41K
Market value
$24.1K
10/9/2025
—Completed
Units to sell
2.41K
Market value
$19.3K
9/23/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.64K
Market value
$17.6K
11/17/2025
Total
Units
10.76K
Value
$109.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
10/24/2025 | 2.68K | $32.1K | — | Completed |
10/16/2025 | 1.64K | $16.6K | — | Completed |
10/9/2025 | 2.41K | $24.1K | — | Completed |
9/23/2025 | 2.41K | $19.3K | — | Completed |
| Planned — Approximate Date | ||||
11/17/2025 | 1.64K | $17.6K | NASDAQ | Planned |
| Total | 10.76K | $109.7K | ||